The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.

The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from ...

A previous federal policy recommended an annual COVID shot for all Americans six months and older. Here is what the new proposal would be.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...